
Lorlatinib Tablet Recommended For: Suitable For The Treatment Of Alk Gene-positive Non-small Cell Lung Cancer (Nsclc) Patients
Price:
Get Latest Price
Product Specifications
Physical Form | Tablets |
Recommended For | Suitable for the treatment of ALK gene-positive non-small cell lung cancer (NSCLC) patients |
Dosage | The recommended dose is 100 mg daily orally, once a day |
Storage Instructions | Dry Place |
Product Overview
Key Features
Dosage form:capsule
Wrap:30 capsules
Specification:25mg or 100mg
Origin:Elemental Pharmaceuticals
Disclaimer
Company Details
Business Type
Exporter, Manufacturer, Supplier, Trading Company
Employee Count
40
Establishment
2015
Working Days
Monday To Sunday
Related Products
Explore Related Categories
Seller Details
Shanghai, Shanghai
Marketing Manager
Mr Yang Chen
Members since
5 Years
Address
Room 618, Zhaojiabang Road 789, Xuhui District, Shanghai, Shanghai, 200000, China
pharmaceutical tablets in Shanghai
Report incorrect details